NDC11 81806021313
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 81806-0213-13 | 81806-0213 |
| 81806-213-13 | 81806-213 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| JAYTHARI Oral Suspension | DEFLAZACORT | Doppel Farmaceutici S.r.l. | 43f3890e-0b1d-9bb5-e063-6294a90aa622 | 2026-09-10 | Warnings, Adverse reactions | 81806-213-13 81806-213 81806021313 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.